Brucke Financial, Inc.

Position in NVS — Novartis AG

CIK 2058446 INDIANAPOLIS, IN

Position in NVS

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$470,003

-$224,093 QoQ

Shares Held

2,999

-34.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#918

of 1,603 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brucke Financial, Inc. holds $4,830,124 across 6 Drug Manufacturers - General names. NVS ranks #5 (9.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,197	$1,435,717
2	JNJ	Johnson & Johnson	4,299	$1,091,817
3	MRK	Merck & Co., Inc.	6,337	$814,304
4	ABBV	AbbVie Inc.	2,810	$707,108
5	NVS	Novartis AG This page	2,999	$470,003
6	GILD	Gilead Sciences, Inc.	2,463	$311,175

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$470,003	2,999	-34.0%	Shares	Sole	2026-07-21
2026-03-31	$694,096	4,544	-22.6%	Shares	Sole	2026-04-10
2025-12-31	$809,434	5,871	+16.2%	Shares	Sole	2026-01-12
2025-09-30	$647,868	5,052	-16.5%	Shares	Sole	2025-11-12
2025-06-30	$732,352	6,052	0.0%	Shares	Sole	2025-07-24
2025-03-31	$674,676	6,052	-1.1%	Shares	Sole	2025-05-08
2024-12-31	$595,634	6,121	—	Shares	Sole	2025-02-27
No filing history on record for this holder in this stock.